Annual CAPEX
$585.00 M
-$143.00 M-19.64%
31 December 2023
Summary:
Gilead Sciences annual capital expenditures is currently $585.00 million, with the most recent change of -$143.00 million (-19.64%) on 31 December 2023. During the last 3 years, it has risen by +$6.00 million (+1.04%). GILD annual CAPEX is now -36.69% below its all-time high of $924.00 million, reached on 31 December 2018.GILD CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$141.00 M
+$11.00 M+8.46%
30 September 2024
Summary:
Gilead Sciences quarterly capital expenditures is currently $141.00 million, with the most recent change of +$11.00 million (+8.46%) on 30 September 2024. Over the past year, it has dropped by -$74.00 million (-34.42%). GILD quarterly CAPEX is now -52.53% below its all-time high of $297.00 million, reached on 30 June 2018.GILD Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$591.00 M
+$19.00 M+3.32%
30 September 2024
Summary:
Gilead Sciences TTM capital expenditures is currently $591.00 million, with the most recent change of +$19.00 million (+3.32%) on 30 September 2024. Over the past year, it has increased by +$6.00 million (+1.03%). GILD TTM CAPEX is now -37.72% below its all-time high of $949.00 million, reached on 31 March 2019.GILD TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -34.4% | +1.0% |
| 3 y3 years | +1.0% | -9.6% | +2.1% |
| 5 y5 years | -29.1% | -30.5% | -28.4% |
GILD CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -19.6% | +1.0% | -42.9% | +34.3% | -18.8% | +7.3% |
| 5 y | 5 years | -36.7% | +1.0% | -42.9% | +34.3% | -32.1% | +7.3% |
| alltime | all time | -36.7% | >+9999.0% | -52.5% | +267.1% | -37.7% | +1168.8% |
Gilead Sciences CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $141.00 M(+8.5%) | $591.00 M(+3.3%) |
| June 2024 | - | $130.00 M(+23.8%) | $572.00 M(-1.5%) |
| Mar 2024 | - | $105.00 M(-51.2%) | $581.00 M(-0.7%) |
| Dec 2023 | $585.00 M(-19.6%) | $215.00 M(+76.2%) | $585.00 M(+6.2%) |
| Sept 2023 | - | $122.00 M(-12.2%) | $551.00 M(-6.0%) |
| June 2023 | - | $139.00 M(+27.5%) | $586.00 M(-0.7%) |
| Mar 2023 | - | $109.00 M(-39.8%) | $590.00 M(-19.0%) |
| Dec 2022 | $728.00 M(+25.7%) | $181.00 M(+15.3%) | $728.00 M(+3.6%) |
| Sept 2022 | - | $157.00 M(+9.8%) | $703.00 M(+2.6%) |
| June 2022 | - | $143.00 M(-42.1%) | $685.00 M(+3.6%) |
| Mar 2022 | - | $247.00 M(+58.3%) | $661.00 M(+14.2%) |
| Dec 2021 | $579.00 M(-10.9%) | $156.00 M(+12.2%) | $579.00 M(-4.1%) |
| Sept 2021 | - | $139.00 M(+16.8%) | $604.00 M(-2.6%) |
| June 2021 | - | $119.00 M(-27.9%) | $620.00 M(-3.7%) |
| Mar 2021 | - | $165.00 M(-8.8%) | $644.00 M(-0.9%) |
| Dec 2020 | $650.00 M(-21.2%) | $181.00 M(+16.8%) | $650.00 M(-3.3%) |
| Sept 2020 | - | $155.00 M(+8.4%) | $672.00 M(-6.3%) |
| June 2020 | - | $143.00 M(-16.4%) | $717.00 M(-5.5%) |
| Mar 2020 | - | $171.00 M(-15.8%) | $759.00 M(-8.0%) |
| Dec 2019 | $825.00 M(-10.7%) | $203.00 M(+1.5%) | $825.00 M(-5.2%) |
| Sept 2019 | - | $200.00 M(+8.1%) | $870.00 M(+3.9%) |
| June 2019 | - | $185.00 M(-21.9%) | $837.00 M(-11.8%) |
| Mar 2019 | - | $237.00 M(-4.4%) | $949.00 M(+2.7%) |
| Dec 2018 | $924.00 M(+56.6%) | $248.00 M(+48.5%) | $924.00 M(+3.1%) |
| Sept 2018 | - | $167.00 M(-43.8%) | $896.00 M(+4.4%) |
| June 2018 | - | $297.00 M(+40.1%) | $858.00 M(+25.4%) |
| Mar 2018 | - | $212.00 M(-3.6%) | $684.00 M(+15.9%) |
| Dec 2017 | $590.00 M(-21.1%) | $220.00 M(+70.5%) | $590.00 M(+9.5%) |
| Sept 2017 | - | $129.00 M(+4.9%) | $539.00 M(-11.3%) |
| June 2017 | - | $123.00 M(+4.2%) | $608.00 M(-11.8%) |
| Mar 2017 | - | $118.00 M(-30.2%) | $689.00 M(-7.9%) |
| Dec 2016 | $748.00 M(+0.1%) | $169.00 M(-14.6%) | $748.00 M(+0.4%) |
| Sept 2016 | - | $198.00 M(-2.9%) | $745.00 M(-10.6%) |
| June 2016 | - | $204.00 M(+15.3%) | $833.00 M(+4.1%) |
| Mar 2016 | - | $177.00 M(+6.6%) | $800.00 M(+7.1%) |
| Dec 2015 | $747.00 M(+34.1%) | $166.00 M(-42.0%) | $747.00 M(-0.1%) |
| Sept 2015 | - | $286.00 M(+67.3%) | $748.00 M(+25.3%) |
| June 2015 | - | $171.00 M(+37.9%) | $597.00 M(+15.5%) |
| Mar 2015 | - | $124.00 M(-25.7%) | $517.00 M(-7.2%) |
| Dec 2014 | $557.00 M(+193.2%) | $167.00 M(+23.7%) | $557.00 M(+21.4%) |
| Sept 2014 | - | $135.00 M(+48.4%) | $458.69 M(+27.1%) |
| June 2014 | - | $91.00 M(-44.5%) | $360.87 M(+14.5%) |
| Mar 2014 | - | $164.00 M(+138.8%) | $315.15 M(+65.9%) |
| Dec 2013 | $190.00 M(-52.1%) | $68.69 M(+84.7%) | $190.00 M(-51.4%) |
| Sept 2013 | - | $37.18 M(-17.9%) | $391.13 M(-7.0%) |
| June 2013 | - | $45.28 M(+16.5%) | $420.54 M(+1.9%) |
| Mar 2013 | - | $38.85 M(-85.6%) | $412.65 M(+3.9%) |
| Dec 2012 | $397.00 M(+201.0%) | $269.82 M(+305.2%) | $397.00 M(+159.0%) |
| Sept 2012 | - | $66.58 M(+78.1%) | $153.28 M(+1.5%) |
| June 2012 | - | $37.39 M(+61.2%) | $150.99 M(+7.7%) |
| Mar 2012 | - | $23.20 M(-11.1%) | $140.23 M(+6.3%) |
| Dec 2011 | $131.90 M(+113.1%) | $26.11 M(-59.4%) | $131.90 M(+2.1%) |
| Sept 2011 | - | $64.29 M(+141.4%) | $129.16 M(+70.7%) |
| June 2011 | - | $26.64 M(+79.1%) | $75.67 M(+16.3%) |
| Mar 2011 | - | $14.87 M(-36.3%) | $65.09 M(+5.2%) |
| Dec 2010 | $61.88 M(-73.1%) | $23.36 M(+116.2%) | $61.88 M(-5.5%) |
| Sept 2010 | - | $10.81 M(-32.7%) | $65.51 M(-10.0%) |
| June 2010 | - | $16.05 M(+37.6%) | $72.83 M(-6.2%) |
| Mar 2010 | - | $11.67 M(-56.8%) | $77.65 M(-66.2%) |
| Dec 2009 | $230.06 M(+100.0%) | $26.99 M(+48.9%) | $230.06 M(-6.0%) |
| Sept 2009 | - | $18.13 M(-13.2%) | $244.73 M(-5.1%) |
| June 2009 | - | $20.87 M(-87.3%) | $258.00 M(-1.6%) |
| Mar 2009 | - | $164.07 M(+293.8%) | $262.33 M(+128.1%) |
| Dec 2008 | $115.00 M | $41.66 M(+32.7%) | $115.00 M(+24.1%) |
| Sept 2008 | - | $31.40 M(+24.6%) | $92.67 M(+25.6%) |
| June 2008 | - | $25.20 M(+50.4%) | $73.77 M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $16.75 M(-13.3%) | $70.36 M(-10.5%) |
| Dec 2007 | $78.65 M(-25.2%) | $19.32 M(+54.6%) | $78.65 M(-12.2%) |
| Sept 2007 | - | $12.50 M(-42.6%) | $89.54 M(-24.4%) |
| June 2007 | - | $21.79 M(-13.0%) | $118.45 M(+2.1%) |
| Mar 2007 | - | $25.04 M(-17.1%) | $115.99 M(+10.2%) |
| Dec 2006 | $105.21 M(+119.4%) | $30.21 M(-27.0%) | $105.21 M(+19.5%) |
| Sept 2006 | - | $41.41 M(+114.3%) | $88.04 M(+52.0%) |
| June 2006 | - | $19.33 M(+35.5%) | $57.91 M(+8.6%) |
| Mar 2006 | - | $14.26 M(+9.3%) | $53.33 M(+11.2%) |
| Dec 2005 | $47.95 M(-6.6%) | $13.04 M(+15.6%) | $47.95 M(-16.1%) |
| Sept 2005 | - | $11.29 M(-23.5%) | $57.18 M(+0.7%) |
| June 2005 | - | $14.75 M(+66.2%) | $56.79 M(+3.5%) |
| Mar 2005 | - | $8.88 M(-60.1%) | $54.89 M(+6.9%) |
| Dec 2004 | $51.37 M(+33.0%) | $22.27 M(+104.3%) | $51.37 M(-192.9%) |
| Sept 2004 | - | $10.90 M(-15.1%) | -$55.30 M(-212.9%) |
| June 2004 | - | $12.84 M(+139.8%) | $48.99 M(+18.6%) |
| Mar 2004 | - | $5.36 M(-106.3%) | $41.29 M(+7.0%) |
| Dec 2003 | $38.61 M(+119.4%) | -$84.39 M(-173.3%) | $38.61 M(-69.9%) |
| Sept 2003 | - | $115.19 M(+2139.7%) | $128.07 M(+647.3%) |
| June 2003 | - | $5.14 M(+92.6%) | $17.14 M(-0.6%) |
| Mar 2003 | - | $2.67 M(-47.4%) | $17.24 M(-2.0%) |
| Dec 2002 | $17.60 M(-33.2%) | $5.08 M(+19.4%) | $17.60 M(-20.7%) |
| Sept 2002 | - | $4.25 M(-18.9%) | $22.19 M(-5.8%) |
| June 2002 | - | $5.24 M(+73.0%) | $23.57 M(-9.7%) |
| Mar 2002 | - | $3.03 M(-68.7%) | $26.11 M(-0.9%) |
| Dec 2001 | $26.33 M(+68.6%) | $9.67 M(+72.0%) | $26.33 M(+27.2%) |
| Sept 2001 | - | $5.62 M(-27.8%) | $20.70 M(+0.1%) |
| June 2001 | - | $7.78 M(+139.2%) | $20.68 M(+36.5%) |
| Mar 2001 | - | $3.25 M(-19.6%) | $15.15 M(-3.0%) |
| Dec 2000 | $15.62 M(+25.0%) | $4.05 M(-27.8%) | $15.62 M(-6.3%) |
| Sept 2000 | - | $5.60 M(+149.1%) | $16.68 M(+30.9%) |
| June 2000 | - | $2.25 M(-39.6%) | $12.74 M(+1.8%) |
| Mar 2000 | - | $3.72 M(-27.0%) | $12.51 M(+0.1%) |
| Dec 1999 | $12.50 M(+13.6%) | $5.10 M(+206.5%) | $12.50 M(+28.9%) |
| Sept 1999 | - | $1.66 M(-17.7%) | $9.70 M(-38.0%) |
| June 1999 | - | $2.02 M(-45.6%) | $15.64 M(+12.4%) |
| Mar 1999 | - | $3.71 M(+61.5%) | $13.91 M(+26.5%) |
| Dec 1998 | $11.00 M(-20.3%) | $2.30 M(-69.7%) | $11.00 M(-43.3%) |
| Sept 1998 | - | $7.60 M(+2433.3%) | $19.40 M(+59.0%) |
| June 1998 | - | $300.00 K(-62.5%) | $12.20 M(-4.7%) |
| Mar 1998 | - | $800.00 K(-92.5%) | $12.80 M(-7.2%) |
| Dec 1997 | $13.80 M(+273.0%) | $10.70 M(+2575.0%) | $13.80 M(+165.4%) |
| Sept 1997 | - | $400.00 K(-55.6%) | $5.20 M(-1.9%) |
| June 1997 | - | $900.00 K(-50.0%) | $5.30 M(+3.9%) |
| Mar 1997 | - | $1.80 M(-14.3%) | $5.10 M(+37.8%) |
| Dec 1996 | $3.70 M(+516.7%) | $2.10 M(+320.0%) | $3.70 M(+131.3%) |
| Sept 1996 | - | $500.00 K(-28.6%) | $1.60 M(+23.1%) |
| June 1996 | - | $700.00 K(+75.0%) | $1.30 M(+85.7%) |
| Mar 1996 | - | $400.00 K(+100.0%) | $700.00 K(-61.1%) |
| Dec 1995 | $600.00 K(-84.6%) | - | - |
| Sept 1995 | - | $200.00 K(+100.0%) | $1.80 M(-51.4%) |
| June 1995 | - | $100.00 K(-50.0%) | $3.70 M(-5.1%) |
| Mar 1995 | - | $200.00 K(-84.6%) | $3.90 M(-2.5%) |
| Mar 1995 | $3.90 M(+21.9%) | - | - |
| Dec 1994 | - | $1.30 M(-38.1%) | $4.00 M(+29.0%) |
| Sept 1994 | - | $2.10 M(+600.0%) | $3.10 M(+34.8%) |
| June 1994 | - | $300.00 K(0.0%) | $2.30 M(-28.1%) |
| Mar 1994 | $3.20 M(-27.3%) | $300.00 K(-25.0%) | $3.20 M(-46.7%) |
| Dec 1993 | - | $400.00 K(-69.2%) | $6.00 M(-6.3%) |
| Sept 1993 | - | $1.30 M(+8.3%) | $6.40 M(+20.8%) |
| June 1993 | - | $1.20 M(-61.3%) | $5.30 M(+20.5%) |
| Mar 1993 | $4.40 M(+780.0%) | $3.10 M(+287.5%) | $4.40 M(+238.5%) |
| Dec 1992 | - | $800.00 K(+300.0%) | $1.30 M(+160.0%) |
| Sept 1992 | - | $200.00 K(-33.3%) | $500.00 K(+66.7%) |
| June 1992 | - | $300.00 K | $300.00 K |
| Mar 1992 | $500.00 K(+66.7%) | - | - |
| Mar 1991 | $300.00 K | - | - |
FAQ
- What is Gilead Sciences annual capital expenditures?
- What is the all time high annual CAPEX for Gilead Sciences?
- What is Gilead Sciences quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Gilead Sciences?
- What is Gilead Sciences quarterly CAPEX year-on-year change?
- What is Gilead Sciences TTM capital expenditures?
- What is the all time high TTM CAPEX for Gilead Sciences?
- What is Gilead Sciences TTM CAPEX year-on-year change?
What is Gilead Sciences annual capital expenditures?
The current annual CAPEX of GILD is $585.00 M
What is the all time high annual CAPEX for Gilead Sciences?
Gilead Sciences all-time high annual capital expenditures is $924.00 M
What is Gilead Sciences quarterly capital expenditures?
The current quarterly CAPEX of GILD is $141.00 M
What is the all time high quarterly CAPEX for Gilead Sciences?
Gilead Sciences all-time high quarterly capital expenditures is $297.00 M
What is Gilead Sciences quarterly CAPEX year-on-year change?
Over the past year, GILD quarterly capital expenditures has changed by -$74.00 M (-34.42%)
What is Gilead Sciences TTM capital expenditures?
The current TTM CAPEX of GILD is $591.00 M
What is the all time high TTM CAPEX for Gilead Sciences?
Gilead Sciences all-time high TTM capital expenditures is $949.00 M
What is Gilead Sciences TTM CAPEX year-on-year change?
Over the past year, GILD TTM capital expenditures has changed by +$6.00 M (+1.03%)